| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 8780174 | Gynecologic Oncology | 2018 | 6 Pages | 
Abstract
												TFAP2B expression may be a potential prognostic molecular marker of poor survival in endometrial cancer, Moreover, the p53/hypoxia, androgen response and notch signaling pathway may be the key pathway regulated by TFAP2B in EC.
											Related Topics
												
													Health Sciences
													Medicine and Dentistry
													Obstetrics, Gynecology and Women's Health
												
											Authors
												Hongrong Wu, Jian Zhang, 
											